Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Macy’s Inc. ( M - Analyst Report ) , one of the leading department store retailers in the U.S., posted strong comparable-store sales (comps) for the four-week period ended July 28, 2012, much better than analysts' expectations. The increase in comps was attributable to continued strength in its online business.
Same-store sales improved 4.1% year over year for the month of July. The company stated that total sales of $1.69 billion for the month of July 2012 reflected an increase of 5.1% from $1.61 billion in the comparable prior-year period.
In spite of the macro-economic headwinds and a temporary suspension in sales due to restoration of flagship stores in New York City, the company continued to perform well in the first half of 2012, reflecting healthy sales in the month of July. Moreover, Macy’s met management’s expectations for the spring season.
Year-to-date, Macy’s sales jumped 3.7% to $12.3 billion compared with $11.8 billion in the same period last year. Macy’s same-store sales also increased 3.7% year-to-date.
Online sales, which include sales from macys.com and bloomingdales.com, continued to grow at a rapid pace, surging 35.1% in July. On a year-to-date basis, online sales shot up 34.8% from the comparable period last year. The company seeks to expand both Macy's and Bloomingdale's brands online.
Macy’s total sales grew 3% to $6.1 billion in the second-quarter 2012 from $5.9 billion in the prior-year period, while same-store sales climbed 3%. Online sales during the quarter soared 36.1%. The company currently operates approximately 840 department stores in 45 states, the District of Columbia, Guam and Puerto Rico.
To Conclude
Macy’s department stores sell a wide range of merchandise. Its products include men’s, women’s, and children’s apparel. It also deals with accessories, cosmetics, home furnishings and other consumer goods.
The company has been taking a number of initiatives in order to increase its sales, profitability and cash flows. These steps include integration of operations, consolidation of divisions as well as developing e-commerce business and online order fulfillment centers.
We remain optimistic about the company’s customer-centric localization initiative called “My Macy’s.” The program aims at improving comparable-store sales and reducing operating expenses, with stores and merchandise assortments focusing on local customer needs and preferences.
However, the company’s expansion in regions where it already serves could cannibalize its sales performance and bring down traffic counts at its existing stores in these areas. Consequently, this may have a negative impact on the company’s overall performance.
Therefore, Macy’s, which competes with J. C. Penney Company Inc. ( JCP - Analyst Report ) , Dillard’s Inc. ( DDS - Analyst Report ) and Saks Incorporated ( SKS - Analyst Report ) , carries a Zacks #3 Rank that translates into a short-term Hold rating. Moreover, we have a long-term Neutral recommendation on the stock.
Read the full Analyst Report on M
Read the full Analyst Report on DDS
Read the full Analyst Report on JCP
Read the full Analyst Report on SKS